ScoreWhy is Venmax Drugs & Pharmaceuticals Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 200.30% and Operating profit at 10.45% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 1.16 times
2
Flat results in Dec 25
3
Stock is technically in a Mildly Bearish range
- A key technical factor - MACD has been Bearish since 11 May 2026
4
With ROE of 4.6, it has a Very Expensive valuation with a 6.3 Price to Book Value
- Over the past year, while the stock has generated a return of -1.36%, its profits have risen by 26% ; the PEG ratio of the company is 0.1
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Venmax Drugs for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Venmax Drugs
-25.45%
-0.03
51.07%
Sensex
-5.44%
-0.64
13.06%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
200.30%
EBIT Growth (5y)
10.45%
EBIT to Interest (avg)
-0.35
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
0.28
Tax Ratio
13.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.73%
ROE (avg)
0.09%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
120
Industry P/E
34
Price to Book Value
5.46
EV to EBIT
21.51
EV to EBITDA
21.51
EV to Capital Employed
11.20
EV to Sales
2.68
PEG Ratio
0.10
Dividend Yield
NA
ROCE (Latest)
-52.08%
ROE (Latest)
4.56%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
PAT(Latest six months)
Higher at Rs 0.05 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Venmax Drugs
Profit After Tax (PAT) - Latest six months
Higher at Rs 0.05 cr
than preceding 12 month period ended Dec 2025 of Rs 0.02 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
